期刊文献+

组织蛋白酶S抑制剂对兔血管平滑肌细胞凋亡的影响

The effect of cathepsin S inhibitor on the apoptosis of rabbit vascular smooth muscle cells
下载PDF
导出
摘要 目的研究组织蛋白酶S抑制剂对培养的兔血管平滑肌细胞凋亡的影响及其机制。方法获取兔主动脉组织,传代培养血管平滑肌细胞,将细胞分为对照组、单药组(血管紧张素Ⅱ)、联合组(组织蛋白酶S抑制剂+血管紧张素Ⅱ);采用流式细胞术和脱氧核糖核苷酸末端转移酶介导的缺II末端标记法(TUNEL)检测血管平滑肌细胞凋亡,蛋白质印迹法检测B细胞淋巴瘤基因.2蛋白、B细胞淋巴瘤基因-2相关蛋白X及半胱氨酸天冬氨酸特异性蛋白酶-3的表达。结果①流式细胞术检查及TUNEL染色结果均显示,联合组血管平滑肌细胞晚期凋亡数量明显低于单药组;TUNEL染色10h和12h时点,单药组与联合组差异有统计学意义[10h:(23607±176)比(36058±269)个,12h:(29813±205)比(39146±263)个,均P〈0.05];②蛋白质印迹检测结果显示,与单药组相比,联合组B细胞淋巴瘤基因-2相关蛋白X/B细胞淋巴瘤基因-2蛋白明显下降,组间差异有统计学意义(P〈0.05);联合组半胱氨酸天冬氨酸特异性蛋白酶-3表达明显降低,组间差异有统计学意义(P〈0.05)。结论组织蛋白酶S抑制剂可能通过下调B细胞淋巴瘤基因-2相关蛋白X、半胱氨酸天冬氨酸特异性蛋白酶-3表达减轻血管平滑肌细胞凋亡。 Objective To observe the effects and mechanisms of Cathepsin S(CTSS) inhibitor on the apop- tosis of vascular smooth muscle cells (VSMC). Methods Vascular smooth muscle cells of rabbit were primary cul- tured from aortic tissue and subcultured. VSMCs were divided into control group, one drug group ( angiotensin I1 ) and combined drugs group ( CTTS inhibitor + angiotensin Ⅱ) ; we used flow cytometry and TUNEL to detect the change of apoptosis of VSMC. Western-blotting was applied to detect the expression of apoptosis related protein Bcl- 2, Bax, Caspase-3. Results ①Both flow cytometry and TUNEL showed that at the time points (10h, 12h), com- pared with one drug group,the apoptosis of VSMC in combined drugs group alleviated remarkably, the difference was statistically significant[ 10h : ( 23607±176 ) vs ( 36058±269 ), 12h : ( 29813±205 ) vs ( 39146±263 ), both P 〈 0.05 ] ②Western-blotting: compared with one drug group, combined drugs group could down-regulate the ratio of the expression of the apoptosis related protein Bax/Bcl-2 obviously ( P 〈 0.05 ) ; the expression of apoptosis related protein Caspase-3 reduced obviously(P 〈0.05). Conclusion Cathepsin S inhibitor may alleviate the apoptosis of VSMC by down-regulating the expression of apoptosis related protein BAX and Caspase-3.
出处 《中国医药》 2012年第7期785-788,共4页 China Medicine
基金 国家自然科学基金资助项目
关键词 肌细胞 平滑肌 组织蛋白酶S 细胞凋亡 Myocytes, smooth muscle Cathepsin S Cell apoptosis
  • 相关文献

参考文献13

  • 1Clarke M, Bennett M . The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Neph- rol,2006,26(6) :531-535.
  • 2Liu J,Sukhova GK, Sun JS, et al. Lysosomal cysteine proteases inatherosclerosis. Arterioscler Tlnomb Vase Bio1,2004,24 (8) : 1359-1366.
  • 3Samokhin AO, Lythgo PA, Gauthier JY,et al. Pharmacological in- hibition of cathepsin S decreases atherosclerotic lesions in Apoe-/- mice. J Cardiovasc Pharmacol,2010,56( 1 ) :98-105.
  • 4Walker B, Lynas JF, Meighan MA, et al. Evaluation of dipeptide alpha-keto-beta-aldehydes as new inhibitors of cathepsin S. Biochem Biophys Res Commun ,2000,275 ( 2 ) :401 405.
  • 5Sasaki T, Kuzuya M, Nakamura K, et al. ATI blockade attenuates atberosclerotic plaque destabilization accompanied by the suppres- sion of cathepsin S activity in apoE-deficient mice. Atherosclerosis, 2010,210(2) :430-437.
  • 6Qin Y, Shi GP. Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. Pharmacol Ther,2011,131 ( 3 ) :338-350.
  • 7顾菲菲,吕树铮.组织蛋白酶S及cystatinC与心血管疾病[J].心脏杂志,2010,22(5):770-773. 被引量:1
  • 8Rodgers KJ, Watkins DJ, Miller AL, et al. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler, Thromb Vasc Biol,2006,26(4) :851-856.
  • 9Suganuma E,Babaev VR,MotimaM,et al. Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes es- tablished atherosclerotic plaques. J Am Soc Nephrol,2007,18( 8 ): 2311-2319.
  • 10Cheng XW, Kuzuya M ,Nakamura K, et al. Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3. Am J Pathol,2006, 168(2) :685694.

二级参考文献27

  • 1Lutgens SP, Cleutjens KB, Demen M J, et al. Cathepsin c vsteine proteases in cardiovascular disease[ J ]. Faeb J, 2007, 21 (12) : 3029 - 3041.
  • 2Benosson E, Nilsson J, Jovinge S. Cystatin C and eathepsins in eardiovascu{ar disease[J]. Front Biosci, 2008, 13:5780 -5786.
  • 3Cheng XW, Kuzuya M, Nakamura K, et al. Localization of cysteine prutease, cathepsin S, to the Surface of vascular smooth muscle cells by association with integrin cv33 [ J ]. Am J Pathol, 2006, 168 (2) :685 -694.
  • 4Nieeoli G, Conte M, Bona RD, et ul. Cystatin C is assiated with an increased eornnary athertsclerotie burden and a stable plaque phenotype in patients with ischemic heart disease and nomral glomerular titration rate [ J ]. Atherosclerosis, 2008, 198 ( 2 ) :373 - 380.
  • 5Manetti L, Pardini E, Genovesi M, et al. Thyroid function differents affects serum cstatin C and creatinine concentrations[ J]. J Endocrinol Invest, 2005, 28 (4) :346 - 349.
  • 6Punturieri A, Filippov S, Allen E, et al. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages[ J ]. J Exp Med, 2000, 192 (6) :789 - 799.
  • 7Lutgens E, Lutgens SP, Faler BC, et al. Disruption of the cathepsin K gene reduces atheroselerosis progression and induces plaque fibrosis but accelerates maerophage foam cell formation [ J ]. Circulatiory, 2006, 113( 1 ) :98 - 107.
  • 8Linke M, Gordon RE, Brillard M, et al. Degradation of apolipoprotein B-100 by lysosomal csteine cathepsins[ J ]. Biol Chem, 2006, 387(9) :1295 - 1303.
  • 9Liu J, Sukhoa GK, Sun JS, et al. Lysosomal cysteine proteases in athcrosclerosis[ J ]. Artrioscler Thromb Vasc Biol, 2004, 24 (8) : 1359 - 1366.
  • 10Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human alherosclerosis and aortic aneurysms[ J ]. J Clin Invest, 1999, 104(9) :1191 - 1197.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部